Global Needle-Free Diabetes Management Market 2017-2025: Adoption Of Needle-Free Diabetes Management In Emerging Markets Presents Major market Opportunity - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Needle-Free Diabetes Management Market Size, Share, Development, Growth and Demand Forecast to 2025" report to their offering.

The global needle-free diabetes management market is expected to witness a CAGR of 17.8% during the forecast period, to reach $16,831.5 million by 2025.

The increasing awareness regarding the safety issues associated with needles is the key growth driver for the global market. Among the different types of needle-free diabetes management devices, artificial pancreas market is expected to witness the fastest growth during the forecast period.

The adoption of needle-free diabetes management in the emerging economies is expected to provide huge growth potential for the market, during the forthcoming years. The growth will be driven by the increasing healthcare awareness, increasing healthcare spending, and regulatory initiatives for needle stick injuries.

The factors driving the growth of the needle-free diabetes management market are growing geriatric population, increasing prevalence of diabetes and technological advancements. The development of technologically advanced diabetes management devices has become necessary to ensure increased healthcare efficiency and productivity. Earlier, diabetic patients needed to prick their fingers to obtain blood sample for frequent glucose level monitoring.

Some of the key players in the global market include Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Inc., Inovio Pharmaceuticals, Inc., Pharmajet, Inc., Zogenix, Inc., Antares Pharma Inc., and Glide Pharmaceutical Technologies Ltd.

Market Outlook

Opportunity In The Global Needle-Free Diabetes Management Market

  • Adoption Of Needle-Free Diabetes Management In Emerging Markets

Factors Driving The Growth Of The Market And Its Impact On Market Forecast

  • Growing Geriatric Population
  • Increasing Prevalence Of Diabetes
  • Technological Advancements
  • Increasing Awareness Regarding The Safety Issues Associated With Needles
  • Impact Analysis Of Drivers On Market Forecast

Factors Hindering Growth Of The Market And Its Impact On Market Forecast

  • Alternative Drug Delivery Methods
  • Stringent Regulatory Requirements
  • Impact Analysis Of Restraints On Market Forecast

Key Company Profiles

  • Glide Pharmaceutical Technologies Ltd.
  • Antares Pharma Inc.
  • Zogenix, Inc.
  • Pharmajet, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Tandem Diabetes Care, Inc.
  • Insulet Corporation
  • Medtronic Plc

For more information about this report visit http://www.researchandmarkets.com/research/56zmg8/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diabetes Devices, Infusions and Injectables, Endocrinology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diabetes Devices, Infusions and Injectables, Endocrinology